{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:50:01Z","timestamp":1791377401053,"version":"4.3.2"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.psyneuen.2024.107274","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:24:23Z","timestamp":1736022263000},"page":"107274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-0851","authenticated-orcid":false,"given":"Bodyl A.","family":"Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Jetske","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna N.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiymet","family":"Bozaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rossell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.C.","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2024.107274_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3856","article-title":"The neuroprotective actions of oestradiol and oestrogen receptors","volume":"16","author":"Arevalo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107274_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-017-0043-3","article-title":"The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis","volume":"4","author":"de Boer","year":"2018","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.psyneuen.2024.107274_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100681","article-title":"Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a study protocol","volume":"20","author":"Brand","year":"2020","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.psyneuen.2024.107274_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YCO.0000000000000699","article-title":"Estrogens in schizophrenia: progress, current challenges and opportunities","volume":"34","author":"Brand","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107274_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11920-023-01460-6","article-title":"Evidence-based recommendations for the pharmacological treatment of women with schizophrenia spectrum disorders","volume":"25","author":"Brand","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107274_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/jcem-34-4-736","article-title":"Interactions between estrogens and catechol amines III. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the catechol-O-methyltransferase of human liver","volume":"34","author":"Ball","year":"1972","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.psyneuen.2024.107274_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/schbul\/sbad058","article-title":"The direct and long-term effects of raloxifene as adjunctive treatment for schizophrenia-spectrum disorders: a double-blind, randomized clinical trial","volume":"49","author":"Brand","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2024.107274_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia","volume":"384","author":"Brannan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2024.107274_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/376578","article-title":"A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain","volume":"73","author":"Bray","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271131","article-title":"Ovariectomy reduces cholinergic modulation of excitatory synaptic transmission in the rat entorhinal cortex","author":"Battal\u00e1n Burrowes","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.psyneuen.2024.107274_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2010.02.032","article-title":"Effects of 17\u03b2-estradiol on expression of muscarinic acetylcholine receptor subtypes and estrogen receptor \u03b1 in rat hippocampus","volume":"634","author":"Cardoso","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/S1355617705050241","article-title":"The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia","volume":"11","author":"Chan","year":"2005","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.psyneuen.2024.107274_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib14","article-title":"Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: Implications for drug development","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psyneuen.2024.107274_bib15","series-title":"Estrogens and Memory","first-page":"96","article-title":"Estrogenic regulation of Glia and neuroinflammation","author":"Crespo-Castrillo","year":"2020"},{"key":"10.1016\/j.psyneuen.2024.107274_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105192","article-title":"The impact of ovariectomy and chronic estrogen treatment on gene expression in the rat cortex: implications for psychiatric disorders","volume":"127","author":"Dean","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107274_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ajmg.b.32440","article-title":"COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex","volume":"171","author":"Dean","year":"2016","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-021-00174-z","article-title":"Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer\u2019s disease and cognition","volume":"7","author":"Dean","year":"2021","journal-title":"npj Schizophr."},{"key":"10.1016\/j.psyneuen.2024.107274_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00221-020-05730-0","article-title":"Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex","volume":"238","author":"Dean","year":"2020","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.psyneuen.2024.107274_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2007.03.031","article-title":"Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls","author":"Diaz-Asper","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107274_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","article-title":"Selective estrogen receptor modulators in clinical practice: a safety overview","volume":"14","author":"Ellis","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.psyneuen.2024.107274_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2017.00578","article-title":"COMT Val158Met polymorphism exerts sex-dependent effects on fMRI measures of brain function","volume":"11","author":"Elton","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107274_bib23","article-title":"SNP genotyping using the sequenom MassARRAY iPLEX platform","volume":"60","author":"Gabriel","year":"2009","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/615356","article-title":"A role for estrogen in schizophrenia: clinical and preclinical findings","volume":"2015","author":"Gogos","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s12017-016-8392-z","article-title":"The role of a catechol-O-methyltransferase (COMT) Val158Met genetic polymorphism in schizophrenia: a systematic review and updated meta-analysis on 32,816 subjects","author":"Gonz\u00e1lez-Castro","year":"2016","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.psyneuen.2024.107274_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(25)06681-5","article-title":"Catecol-o-methyl transferase: pharmacological aspects and physiological role","volume":"27","author":"Guldberg","year":"1975","journal-title":"Phermacol Rev"},{"key":"10.1016\/j.psyneuen.2024.107274_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/156652411798062386","article-title":"Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia","volume":"11","author":"Gupta","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.psyneuen.2024.107274_bib28","article-title":"Pharmacokinetics of raloxifene and its clinical application","volume":"7","author":"Hochner-Celnikier","year":"1999","journal-title":"Eur. J. Obstet., Gynecol., Reprod. Biol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.ejhg.5201164","article-title":"Detection of genotyping errors by Hardy\u2013Weinberg equilibrium testing","volume":"12","author":"Hosking","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2024.107274_bib31","article-title":"The relationship between cognition and functioning in schizophrenia: a semi-systematic review","volume":"27","author":"Kharawala","year":"2022","journal-title":"Schizophr. Res.: Cogn."},{"key":"10.1016\/j.psyneuen.2024.107274_bib32","article-title":"A placebo-controlled study of raloxifene added to risperidone in men with chronic schizophrenia","author":"Khodaie-Ardakani","year":"2015","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.psyneuen.2024.107274_bib33","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.euroneuro.2016.10.009","article-title":"Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype","volume":"26","author":"Kindler","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/YPG.0b013e32832cee98","article-title":"Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population","volume":"19","author":"Kishi","year":"2009","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2013.03.001","article-title":"Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation","volume":"49","author":"Kokawa","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2024.107274_bib36","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.euroneuro.2016.08.006","article-title":"Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial","volume":"26","author":"Labad","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2024.107274_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/acps.13530","article-title":"Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"147","author":"Li","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2024.107274_bib39","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","article-title":"Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme","volume":"34","author":"Lotta","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.psyneuen.2024.107274_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archneur.57.2.236","article-title":"Lack of an association of estrogen receptor \u03b1 gene polymorphisms and transcriptional activity with alzheimer disease","volume":"57","author":"Maruyama","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2003.10.003","article-title":"Involvement of GABAA receptors in the regulation of the prefrontal cortex on dopamine release in the rat dorsolateral striatum","volume":"482","author":"Matsumoto","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1590\/1516-4446-2016-1987","article-title":"Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls","volume":"39","author":"Matsuzaka","year":"2017","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.psyneuen.2024.107274_bib43","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107274_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yhbeh.2006.10.007","article-title":"Estrogen Therapy and brain muscarinic receptor density in healthy females: a SPET study","volume":"51","author":"Norbury","year":"2007","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2024.107274_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2009.02.019","article-title":"Meta-analysis of association between genetic variants in COMT and schizophrenia: an update","author":"Okochi","year":"2009","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.psyneuen.2024.107274_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annual review of pharmacology and toxicology"},{"key":"10.1016\/j.psyneuen.2024.107274_bib47","unstructured":"Overbeek, I., Schruers, K., Griez, E., 1999. Mini international neuropsychiatric interview: Nederlandse versie 5.0. 0. DSM-IV [Dutch version]. Maastricht, The Netherlands \u2026."},{"key":"10.1016\/j.psyneuen.2024.107274_bib48","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.euroneuro.2015.10.005","article-title":"Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia","volume":"25","author":"Papaleo","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s10038-018-0511-2","article-title":"Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex","volume":"63","author":"Parkin","year":"2018","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biopsych.2005.04.047","article-title":"Alteration in estrogen receptor \u03b1 mRNA levels in frontal cortex and hippocampus of patients with major mental illness","volume":"58","author":"Perlman","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107274_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuropsychologia.2007.10.009","article-title":"Planning, decision-making and the COMT rs4818 polymorphism in healthy males","volume":"46","author":"Roussos","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.psyneuen.2024.107274_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/0960-0760(94)90193-7","article-title":"Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells","author":"Sch\u00fctze","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.psyneuen.2024.107274_bib53","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/344514","article-title":"A highly significant association between a COMT haplotype and schizophrenia","volume":"71","author":"Shifman","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/hmg\/ddm347","article-title":"A network of dopaminergic gene variations implicated as risk factors for schizophrenia","volume":"17","author":"Talkowski","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2010_97","article-title":"Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders","volume":"8","author":"Tunbridge","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107274_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-9081-9-12","article-title":"Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia","volume":"9","author":"Wang","year":"2013","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.psyneuen.2024.107274_bib57","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/hmg\/ddn130","article-title":"Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia","volume":"17","author":"Weickert","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2024.107274_bib58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mp.2015.11","article-title":"Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia","volume":"20","author":"Weickert","year":"2015","journal-title":"Mol. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:41:56Z","timestamp":1740667316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453024003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":58,"alternative-id":["S0306453024003196"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107274","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107274"}}